MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients
Clin. transl. oncol. (Print)
; 18(5): 449-456, mayo 2016. tab, graf
Article
in En
| IBECS
| ID: ibc-151177
Responsible library:
ES1.1
Localization: BNCS
ABSTRACT
Purpose: To explore the role of miR-33b in colorectal cancer (CRC) and the correlation between its expression and prognosis. Methods: The expressions of miR-33b between CRC tissues and normal tissues were measured by real-time PCR. The effects of miR-33b on cell proliferation and cell cycle progression were detected by MTT assay, colony formation assay and flow cytometry. The potential regulations of miR-33b on multiple genes expression were verified by Western blot. Furthermore, the association of miR-33b with CRC clinicopathologic features and prognosis was analyzed by Chi-squared test and Kaplan-Meier tests. Results: MiR-33b was downregulated in CRC compared with normal colorectal samples and miR-33b inhibited tumor cell growth and induced cell cycle arrest. Western blot assays and correlation analysis showed that miR-33b could regulate multiple growth-related genes. Moreover, the expression of miR-33b was associated with TNM stage and tumor size, and CRC patients with high miR-33b expression had a better prognosis. Conclusion: Our data suggest that miR-33b functions as a tumor suppressor gene in CRC through regulating cell proliferation and cell cycle (AU)
RESUMEN
No disponible
Search on Google
Collection:
06-national
/
ES
Database:
IBECS
Main subject:
Prognosis
/
RNA
/
Colorectal Neoplasms
/
Cell Cycle
/
Blotting, Western
/
Flow Cytometry
Type of study:
Evaluation_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Clin. transl. oncol. (Print)
Year:
2016
Document type:
Article